| Year |
Citation |
Score |
| 2014 |
Carl SM, Herrera-Ruiz D, Bhardwaj RK, Gudmundsson O, Knipp GT. Peptide Transporters Drug Transporters: Molecular Characterization and Role in Drug Disposition: Second Edition. 67-90. DOI: 10.1002/9781118705308.ch5 |
0.731 |
|
| 2012 |
Roth WJ, Lindley DJ, Carl SM, Knipp GT. The effects of intralaboratory modifications to media composition and cell source on the expression of pharmaceutically relevant transporters and metabolizing genes in the Caco-2 cell line. Journal of Pharmaceutical Sciences. 101: 3962-78. PMID 22786684 DOI: 10.1002/Jps.23241 |
0.763 |
|
| 2012 |
Lindley DJ, Roth WJ, Carl SM, Knipp GT. The effects of media on pharmaceutically relevant transporters in the human HT-29 adenocarcinoma cell line: does culture media need to be controlled? Journal of Pharmaceutical Sciences. 101: 1616-30. PMID 22213613 DOI: 10.1002/Jps.23036 |
0.761 |
|
| 2012 |
Carl SM, Lindley DJ, Das D, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT. Correction to “ABC and SLC Transporter Expression and Proton Oligopeptide Transporter (POT) Mediated Permeation across the Human Blood–Brain Barrier Cell Line, hCMEC/D3” Molecular Pharmaceutics. 9: 3606-3606. DOI: 10.1021/Mp300626K |
0.784 |
|
| 2011 |
Lindley DJ, Carl SM, Mowery SA, Knipp GT. THE EVALUATION OF PEPTIDE/HISTIDINE TRANSPORTER 1 (PHT1) FUNCTION: UPTAKE KINETICS UTILIZING A COS-7 STABLY TRANSFECTED CELL LINE. Revista Mexicana De Ciencias Farmaceutica. 42: 57-65. PMID 23888104 |
0.798 |
|
| 2011 |
Lindley DJ, Carl SM, Herrera-Ruiz D, Pan LF, Karpes LB, Goole JME, Gudmundsson OS, Knipp GT. Drug Transporters and Their Role in Absorption and Disposition of Peptides and Peptide-Based Pharmaceuticals Oral Bioavailability: Basic Principles, Advanced Concepts, and Applications. 291-308. DOI: 10.1002/9781118067598.ch18 |
0.622 |
|
| 2010 |
Carl SM, Lindley DJ, Das D, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT. ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected]. Molecular Pharmaceutics. 7: 1057-68. PMID 20524699 DOI: 10.1021/Mp900178J |
0.788 |
|
| 2010 |
Goole J, Lindley DJ, Roth W, Carl SM, Amighi K, Kauffmann JM, Knipp GT. The effects of excipients on transporter mediated absorption. International Journal of Pharmaceutics. 393: 17-31. PMID 20417699 DOI: 10.1016/J.Ijpharm.2010.04.019 |
0.748 |
|
| 2007 |
Mathis AS, Jin S, Friedman GS, Peng F, Carl SM, Knipp GT. The pharmacodynamic effects of sirolimus and sirolimus-calcineurin inhibitor combinations on macrophage scavenger and nuclear hormone receptors. Journal of Pharmaceutical Sciences. 96: 209-22. PMID 17016853 DOI: 10.1002/Jps.20751 |
0.578 |
|
| 2007 |
Oliver E, Carl SM, Morris KR, Becker GW, Knipp GT. Regulatory Considerations in Approval on Follow-on Protein Drug Products Pharmaceutical Manufacturing Handbook: Production and Processes. 33-57. DOI: 10.1002/9780470259818.ch2 |
0.618 |
|
| 2007 |
Carl SM, Lindley DJ, Knipp GT, Morris KR, Oliver E, Becker GW, Arnold RD. Biotechnology-Derived Drug Product Development Pharmaceutical Manufacturing Handbook: Production and Processes. 1-32. DOI: 10.1002/9780470259818.ch1 |
0.737 |
|
| 2006 |
Carl SM, Herrera-Ruiz D, Bhardwaj RK, Gudmundsson O, Knipp GT. Mammalian Oligopeptide Transporters Drug Transporters: Molecular Characterization and Role in Drug Disposition. 105-145. DOI: 10.1002/9780470140505.ch6 |
0.709 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Stern W, Mehta N, Carl SM. Peptide delivery - Oral delivery of peptides by peptelligence technology Drug Development and Delivery. 13. |
0.286 |
|
| 2014 |
Wilkins HM, Carl SM, Swerdlow RH. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biology. 2: 619-631. PMID 25460729 DOI: 10.1016/J.Redox.2014.03.006 |
0.236 |
|
| 2018 |
Xu W, Sank M, Cummings J, Carl S, Juhel M, Gleason C, Dodge R, DeSilva BS, Kolaitis G, Pillutla R. Bead-extraction and heat-dissociation (BEHD): A novel way to overcome drug and matrix interference in immunogenicity testing. Journal of Immunological Methods. PMID 30099014 DOI: 10.1016/j.jim.2018.08.003 |
0.186 |
|
| 2016 |
Wilkins HM, Koppel S, Carl SM, Ramanujan S, Weidling I, Michaelis ML, Michaelis EK, Swerdlow RH. Oxaloacetate Enhances Neuronal Cell Bioenergetic Fluxes and Infrastructure. Journal of Neurochemistry. PMID 26811028 DOI: 10.1111/Jnc.13545 |
0.154 |
|
| 2022 |
Yang Z, Rajendran S, Spires V, Poirson B, Gururajan M, Lin Z, Arbanas J, Krystek S, Loy J, Cheng Y, Carl S, Pace S, Wang Y, Mehl J, Xu S, et al. . Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 35545256 DOI: 10.1124/dmd.121.000799 |
0.116 |
|
| 2015 |
Wilkins HM, Carl SM, Weber SG, Ramanujan SA, Festoff BW, Linseman DA, Swerdlow RH. Mitochondrial lysates induce inflammation and Alzheimer's disease-relevant changes in microglial and neuronal cells. Journal of Alzheimer's Disease : Jad. 45: 305-18. PMID 25537010 DOI: 10.3233/Jad-142334 |
0.106 |
|
| 2018 |
Sankar K, Krystek SR, Carl SM, Day T, Maier JKX. AggScore: Prediction of Aggregation-Prone Regions in Proteins based on the Distribution of Surface Patches. Proteins. PMID 30168197 DOI: 10.1002/prot.25594 |
0.095 |
|
| 2014 |
Wilkins HM, Harris JL, Carl SM, E L, Lu J, Eva Selfridge J, Roy N, Hutfles L, Koppel S, Morris J, Burns JM, Michaelis ML, Michaelis EK, Brooks WM, Swerdlow RH. Oxaloacetate activates brain mitochondrial biogenesis, enhances the insulin pathway, reduces inflammation and stimulates neurogenesis. Human Molecular Genetics. 23: 6528-41. PMID 25027327 DOI: 10.1093/Hmg/Ddu371 |
0.075 |
|
| 2022 |
Yang Z, Loy J, Poirson B, Dai Y, Rajendran S, Xu S, Spires V, Gururajan M, Lin Z, Arbanas J, Carl S, Pace S, Wang Y, Mehl J, Vasudevan K, et al. Application of Pharmacokinetic/Pharmacodynamic Modeling to Bridge Mouse Antitumor Efficacy and Monkey Toxicology Data for Determining the Therapeutic Index of an Interleukin-10 Fc Fusion Protein. Frontiers in Pharmacology. 13: 829063. PMID 35795558 DOI: 10.3389/fphar.2022.829063 |
0.071 |
|
| 2015 |
Selfridge JE, Wilkins HM, E L, Carl SM, Koppel S, Funk E, Fields T, Lu J, Tang EP, Slawson C, Wang W, Zhu H, Swerdlow RH. Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. Journal of Bioenergetics and Biomembranes. 47: 1-11. PMID 25104046 DOI: 10.1007/S10863-014-9570-Z |
0.053 |
|
| 2014 |
Wilkins HM, Carl SM, Greenlief AC, Festoff BW, Swerdlow RH. Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Frontiers in Aging Neuroscience. 6: 311. PMID 25426068 DOI: 10.3389/Fnagi.2014.00311 |
0.041 |
|
| Hide low-probability matches. |